FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:1932 December 12, 2002 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

View larger version (81K): [in this window] [in a new window]   A 45-year-old man with a biopsy-proven pineal tumor was on the seventh day of his first cycle of chemotherapy when symptoms of meningeal irritation and confusion developed. Polymerase chain reaction of cerebrospinal fluid revealed herpes simplex virus type 2, and after acyclovir treatment he appeared to make a complete recovery. However, during his third cycle of chemotherapy, he had severe visual loss, and the diagnosis of bilateral acute retinal necrosis was made. Despite therapy, retinal detachment and ischemic optic neuropathy ensued, and the patient was left with no light perception bilaterally.

 

Peter W. Hadden, F.R.A.N.Z.C.O.
Christopher J. Barry, M.Med.Sci.
Lions . . . [Full Text of this Article]

This article has been cited by other articles:

• Vandercam, T., Hintzen, R. Q., de Boer, J. H., Van der Lelij, A. (2008). Herpetic encephalitis is a risk factor for acute retinal necrosis. Neurology 71: 1268-1274 [Abstract] [Full Text]  
• Kittan, N. A., Bergua, A., Haupt, S., Donhauser, N., Schuster, P., Korn, K., Harrer, T., Schmidt, B. (2007). Impaired Plasmacytoid Dendritic Cell Innate Immune Responses in Patients with Herpes Virus-Associated Acute Retinal Necrosis. J. Immunol. 179: 4219-4230 [Abstract] [Full Text]